Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 449 followers
Latest posts
Last updated about 20 hours ago
Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation: 23/06/2025, Revision: 2, Status: Authorised
10 days ago
Human medicines European public assessment report (EPAR): Yaxwer, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation: 15/07/2026, Revision: 1, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Vislyfa, ranibizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation: 16/12/2019, Revision: 35, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Rinvoq, upadacitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 25, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 13, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 11, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation: 19/09/2024, Revision: 5, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Vyloy, zolbetuximab, Date of authorisation...
Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of authorisation: 22/12/2011, Revision: 8, Status: Withdrawn
about 23 hours ago
Human medicines European public assessment report (EPAR): Repaglinide Accord, repaglinide, Date of...
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 15, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation...
Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica, subsp. enterica, serovar Typhimurium, strain Nal2/Rif9/Rtt, Live, Status: Opinion
1 day ago
Veterinary medicines European public assessment report (EPAR): AviGate S. Typhimurium, Salmonella enterica...
Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive
1 day ago
Summary of opinion: Firocoxib CP-Pharma, 10/09/2026 Positive